Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on March 18, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to Sole Source Exakt Model 312 Pathology Saw

Closed
HT941025N0057Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

San Diego, CA, 92134, USA

Set-Aside

NONE

Documents

1

Notice of Intent to Sole Source - HT941025N0057 (Exakt Pathology Saw)

PDF, Low prioritypresolicitation
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency (dha)
Contacts2 people available
OfficeN/A
Office AddressN/A
Contacts
Bobbie Dobberstein
Michelle Sanders

Full Description

Show more
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract to supply and install the Exakt Model 312 Pathology Saw for the Anatomic Pathology Division at Naval Medical Center San Diego (NMCSD) in accordance with Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government's needs, to: EXAKT TECHNOLOGIES, INC. 13501 RAILWAY DR, OKLAHOMA CITY, OK 73114-2283 UEI: L1D4N2NY24C6 CAGE: 3FC32 The North American Industry Classification System (NAICS) code for this requirement is 339113 - Surgical Appliance and Supplies Manufacturing; the business size standard is 800 (# of employees). The Product Service Code (PSC) is 6515 - Medical and Surgical Instruments, Equipment, and Supplies. The requirement is for a supply purchase order and installation of Exakt Model 312 Pathology Saw. The vendor will provide and install the unit and all associated parts and/or accessories required to leave the unit fully operational. The vendor will provide on-site training to ensure the unit is operated and maintained in a safe and effective manner. Location: NMCSD - 34800 Bob Wilson Dr, San Diego, CA 92134. Estimated Delivery Date: 15 April 2025 Based on market research and previous acquisition history, it has been determined that Exakt Technologies, Inc., is the only source that can meet the Government's specialized requirement. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required pathology saw locally. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Michelle Sanders at contact@example.gov and Bobbie Dobberstein at contact@example.gov. The closing date for challenges is no later than 10:00 a.m. (Pacific), 20 March 2025. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

More opportunities from Department Of Defense → Defense Health Agency (dha)

Same awarding agency

NAICS: 561910
Federal
DHA - Offsite Sterile Processing Support Services
Solicitation # HT9427-27-RFI-0001
The Defense Health Agency (DHA) is conducting market research through a Request for Information (RFI) to identify qualified contractors capable of providing offsite sterile processing (SPD) support for various Military Treatment Facilities (MTFs). The primary goal is to enhance service resilience and workload stability by outsourcing the decontamination, assembly, and sterilization of surgical instruments, including minimally invasive surgical cases, power equipment, and Da Vinci accessories. The scope of work requires the contractor to manage the entire logistics chain, including providing transport containers and ensuring the secure, environmentally controlled transportation of contaminated instruments to offsite facilities and the return delivery of sterile inventory. This effort covers numerous MTFs across the United States, with specific critical locations designated as requiring no interruptions in service. Potential providers must adhere to rigorous industry and federal standards, including ANSI/AAMI ST79 and ST58, FDA 21 CFR Part 820, and various OSHA and DOT regulations. While the government has provided a general planning estimate of approximately 2,000 trays per month, final contract terms, award structures, and small business set-aside determinations will be decided based on the capabilities and feedback received from industry respondents. This is strictly a fact-finding mission and does not constitute a formal solicitation or an obligation to award a contract.
Packaging and Labeling Services

POSTED

7 days ago

DEADLINE

in 9 days
View Details
NAICS: 541715
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

29 days ago

DEADLINE

N/A
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS